Covenant Health has announced the launch of CAR T-cell therapy at the Joe Arrington Cancer Research & Treatment Center (JACC) ...

During a Q2 earnings call, the firm discussed progress on an FGFR2b antibody, a subcutaneous version of Blincyto, and ...

Mutations in a single gene, HNF1A, are known to cause MODY3, a rare, early-onset form of diabetes. Smaller-scale mutations in ...

The virus is already known to raise the risk of six types of cancer, including anal, head and neck, throat and a number of ...

Mutations in a single gene, HNF1A, are known to cause MODY3, a rare, early onset form of diabetes. Smaller scale mutations in the very same gene are ...

Maharashtra CET Cell is set to release today i.e. Tuesday August 05, 2025 on its official website dse2025.mahacet.org.in ...

FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development ...

Second patient in the first cohort is now advancing through protocol-defined evaluations as Company provides promising update on first patient pharmacokinetic results SOUTH SAN FRANSCISCO, Calif., Jul ...

Second patient in the first cohort is now advancing through protocol-defined evaluations as Company provides promising update on first patient pharmacokinetic results ...

Boca Raton, Florida, July 31, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the "Company”), a clinical-stage ...

"Bleeds on the brain due to high blood pressure, or again, vessel damage. And all of these things, they interrupt the oxygen ...